- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Venture Creation Firm Reveals Strategies for Launching New Companies & Forming Collaborations
An expert from Flagship Pioneering, the venture creation firm behind Moderna and other life science firms, shares the process of founding a company, how they decide whether to partner with companies, the importance of collaboration and how they approach it, and where science is booming in pharma right now.
In this exclusive Pharm Exec Podcast episode with Paul Biondi, executive partner at Flagship Pioneering (the venture creation firm behind Moderna and many other life science firms) and president of Pioneering Medicines, Meg Rivers, managing editor, asks Biondi about:
- The process of founding a company
- What factors they consider when deciding whether to partner with a pharmaceutical company (like their partnership with Novo Nordisk) or a foundation (like their partnership with the Cystic Fibrosis Foundation)—along with what makes one organization stand out from another
- Where science is booming in pharma right now
- Deciding whether to found a company looking to launch innovations in an existing space vs. pursue innovations in an untapped space
- Signs that a company will achieve commercial success from early on
About the speaker
Paul Biondi is an executive partner at Flagship Pioneering and president of Pioneering Medicines. In his role at Flagship, Biondi works with growth company CEOs and their teams to achieve the best attainable value for each company and serves on the boards of selected Flagship companies, including Seres Therapeutics and Valo Health. Biondi joined Flagship following many years at Bristol-Myers Squibb where he held senior leadership roles in both business development and research and development.
About the Pharm Exec Podcast
The editors of Pharmaceutical Executivebring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
